申请人:Taiho Pharmaceutical Co., Ltd.
公开号:US05990139A1
公开(公告)日:1999-11-23
This invention relates to a thiazolidinedione derivative represented by the following formula (1): ##STR1## wherein R.sup.1 and R.sup.2 individually represent H, a halogen atom, or a halogen-substituted or -unsubstituted lower alkyl or alkoxy group, and R.sup.1 and R.sup.2 may be coupled together to form a ring of an alkylenedioxy chain, X represents a nitrogen atom or a CH group, A represents a substituted or unsubstituted imidazolidinone, pyrrolidinone, imidazole or pyrazole ring, or a salt thereof; and a pharmaceutical composition containing the thiazolidinedione derivative or a salt thereof. The above compound has excellent blood sugar-lowering action and blood lipid-lowering action and is useful as a therapeutic agent for diabetes.
本发明涉及一种由以下式(1)表示的噻唑烷二酮衍生物:##STR1##其中,R.sup.1和R.sup.2分别表示H,卤素原子或卤素取代或未取代的较低烷基或烷氧基,且R.sup.1和R.sup.2可以耦合形成烷二氧基链的环;X表示氮原子或CH基,A表示取代或未取代的咪唑烷酮,吡咯烷酮,咪唑或吡唑环或其盐;以及含有噻唑烷二酮衍生物或其盐的制药组合物。上述化合物具有出色的降血糖作用和降血脂作用,并可用作糖尿病治疗剂。